Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-1/Smad Pathway and Epithelial to Mesenchymal Transition

被引:16
|
作者
Meng, Lihong [1 ]
Zhang, Xiaomei [2 ]
Wang, Hong [3 ,4 ]
Dong, Huan [1 ]
Gu, Xiaofeng [1 ]
Yu, Xiaolin [1 ]
Liu, Yushan [1 ]
机构
[1] Beijing Univ Chinese Med, 11 North 3rd Ring Rd, Beijing 100029, Peoples R China
[2] Beijing Univ Chinese Med, Dongfang Hosp, Dept Resp Med, 6 1st Dist Fangxingyuan, Beijing 100078, Peoples R China
[3] Shunyi Hosp, Beijing Chinese Med Hosp, 5 Zhanqian East St, Beijing 101300, Peoples R China
[4] Capital Med Univ, Beijing Chinese Med Hosp, Art Museum, 23 Houjie St, Beijing 100010, Peoples R China
关键词
MYOFIBROBLAST; ACTIVATION; MECHANISMS; RECEPTOR;
D O I
10.1155/2019/2710509
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-1/Smad signal pathway and epithelial to mesenchymal transition (EMT). Methods. 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson's trichrome to observe histopathological changes. Protein levels of TGF-1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-1, TRI, TRII, Smad3, Smad7, -SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. Results. TGF-1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I were significantly increased (p <0.01), while Smad7 and E-cadherin levels were significantly decreased in BLM group (p <0.01). YYYQ-M and YYYQ-H group had downregulated the TGF-1, CTGF, hydroxyproline contents, and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p <0.01 or p <0.05). The result from the present study, which was also supported by histological evidence, suggested that YYYQ-M group and YYYQ-H group exhibited better treatment effect on Bleomycin-induced pulmonary fibrotic rats when compared to that of BLM + Pred group (p <0.01). Meanwhile, the effect of YYYQ, in three different dosages, on the level of interleukin 18 was not significant. Conclusion. These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway
    Alaaeldin, Rania
    Mohyeldin, Reham H.
    Bekhit, Amany Abdlrehim
    Gomaa, Wafaey
    Zhao, Qing-Li
    Fathy, Moustafa
    MOLECULES, 2023, 28 (12):
  • [2] Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-ß1 signaling pathway
    Miao, Yang
    Li, Xiaohe
    Yang, Yue
    Zhang, Jianwei
    Chen, Li
    Zhang, Qianyi
    Li, Wenqi
    Liu, Ying
    Zhang, Xianfeng
    Gu, Ruimin
    Yang, Cheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [3] Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation
    Ruijuan Guan
    Xia Wang
    Xiaomei Zhao
    Nana Song
    Jimin Zhu
    Jijiang Wang
    Jin Wang
    Chunmei Xia
    Yonghua Chen
    Danian Zhu
    Linlin Shen
    Scientific Reports, 6
  • [4] Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation
    Guan, Ruijuan
    Wang, Xia
    Zhao, Xiaomei
    Song, Nana
    Zhu, Jimin
    Wang, Jijiang
    Wang, Jin
    Xia, Chunmei
    Chen, Yonghua
    Zhu, Danian
    Shen, Linlin
    SCIENTIFIC REPORTS, 2016, 6
  • [5] Polydatin prevents bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/Smad/ERK signaling pathway
    Liu, Yan-Lu
    Chen, Bao-Yi
    Nie, Juan
    Zhao, Guang-Hui
    Zhuo, Jian-Yi
    Yuan, Jie
    Li, Yu-Cui
    Wang, Ling-Li
    Chen, Zhi-Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (05)
  • [6] Oleanolic acid acetate ameliorates bleomycin-induced pulmonary fibrosis through inhibition of epithelial-mesenchymal transition
    Kim, Hak-Ryul
    Hwang, Ki-Eun
    Park, Chul
    Jung, Jae-Wan
    Jeong, Eun-Taik
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] Yiqi Huayu decoction alleviates bleomycin-induced pulmonary fibrosis in rats by inhibiting senescence
    Zuo, Biao
    Zuo, Ling
    Du, Xu-Qin
    Yuan, Su
    Xuan, Chen
    Zhang, Yu-Di
    Chen, Zhi-Wei
    Cao, Wen-Fu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition
    Han, Qian
    Lin, Lianjun
    Zhao, Beilei
    Wang, Nanping
    Liu, Xinmin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 500 (04) : 839 - 845
  • [9] Polydatin ameliorates pulmonary fibrosis by suppressing inflammation and the epithelial mesenchymal transition via inhibiting the TGF-/Smad signaling pathway
    Qiu, Yue
    Pan, Xue
    Hu, Yahui
    RSC ADVANCES, 2019, 9 (14) : 8104 - 8112
  • [10] Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition
    Zhou, Yan
    He, Zhong
    Gao, Yuan
    Zheng, Rui
    Zhang, Xiaoye
    Zhao, Li
    Tan, Mingqi
    FRONTIERS IN PHARMACOLOGY, 2016, 7